DexCom, Inc. — Earnings Quality Grade A
DXCM · Healthcare
Strong financial health
Screening Summary
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 95 days, change +4 days YoY
AR growth 20.9% vs revenue growth 15.6%
Revenue 15.6%, CFFO 45.6%. Cash follows revenue
Expense Quality
Inventory 15.9% vs COGS 16.6%. Normal
CapEx growth 1.3% vs revenue 15.6%. Normal
SG&A/Gross Profit = 46.1%. Normal
Gross margin 60.1%, change -0.4pp. Stable
Cash Flow Quality
CFFO/NI = 1.72. Profits backed by cash
FCF $1.1B, FCF/NI = 1.29
Accruals ratio = -9.5%. Low accruals
Cash $2.0B covers debt $1.4B
Balance Sheet Health
Goodwill+Intangibles $0.1B = 3% of equity. Manageable
Debt/EBITDA = 1.0x. Healthy
Other assets 9.0% vs revenue 15.6%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -25% YoY. Normal
Manipulation Score
M-Score = -2.71 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-08